Biofilm is an aggregate of consortium bacteria that adhere to each other on a surface. It is usually protected by the exopolysaccharide layer. Various invasive medical procedures, such as catheterization, endotracheal tube installation, and contact lens utilization, are vulnerable to biofilm infection. The National Institute of Health (NIH) estimates 65% of all microbial infections are caused by biofilm. Periplasmic α-amylase (MalS) is an enzyme that hydrolyzes α-1, 4-glicosidic bond in glycogen, starch, and others related polysaccharides in periplasmic space. Another protein called hemolysin-α (HlyA) is a secretion signal protein on C terminal of particular peptide in gram negative bacteria. We proposed a novel recombinant plasmid expressing α-amylase and hemolysin-α fusion in pSB1C3 which is cloned into E.coli to enable α-amylase excretion to extracellular for degrading biofilm polysaccharides content, as in starch agar.Microtiter assay was performed to analyze the reduction percentage of biofilm by adding recombinant E.coli into media. This system is more effective in degrading biofilm from gram positive bacteria i.e.: Bacillus substilis (30.21%) and Staphylococcus aureus (24.20%), and less effective degrading biofilm of gram negative i.e.: Vibrio cholera (5.30%), Pseudomonas aeruginosa (8.50%), Klebsiella pneumonia (6.75%) and E. coli (-0.6%). Gram positive bacteria have a thick layer of peptidoglycan, causing the enzyme to work more effectively in degrading polysaccharides. AbstrakEkspresi dan Penelitian Fungsi Protein Fusi α-Amilase dan Hemolisin-α sebagai suatu Penerapan dalam Penurunan Polisakarida Biofilm. Biofilm adalah sekumpulan bakteria yang saling melekat satu sama lain pada suatu permukaan. Biofilm ini biasanya dilindungi oleh lapisan eksopolisakarida. Berbagai prosedur medis yang pro-aktif, seperti kateterisasi, instalasi alat bantuan pernafasan, dan penggunaan lensa kontak mata, rentan terhadap infeksi biofilm. NIH (National Institute of Health -Institusi Kesehatan Nasional) memperkirakan 65% dari semua infeksi mikroba disebabkan oleh biofilm. Enzim α-amilase periplasma (MalS) merupakan suatu enzim yang menghidrolisis α-1, ikatan 4-glikosidik dalam glikogen, zat tepung, dan lainnya terkait polisakarida pada ruang periplasma. Protein lainnya yang disebut hemolisin-α (HlyA) merupakan protein sinyal sekresi pada terminal C dari peptida tertentu dalam bakteria gram-negatif. C merupakan protein sinyal sekresi pada terminal C dari peptida tertentu dalam bakteria gram-negatif. Kami mengusulkan suatu plasmid rekombinan baru mengekspresikan fusi α-amilase and hemolisin-α dalam pSB1C3 yang diklon menjadi E. coli untuk memungkinkan ekskresi α-amilase ke luar sel tubuh (ekstraselular) untuk menurunkan isi polisakarida biofilm, seperti dalam agar zat tepung. Tes dengan tabung kecil dilakukan untuk menganalisis persentase pengurangan biofilm dengan menambahkan E. coli rekombinan ke dalam media. Sistem ini lebih efektif dalam menurunkan tingkat biofilm dari bakteria gram-positif, seperti Bacillus subst...

Objective:The aim of the present study was to determine whether curcumin (CM) can prevent drug sensitivity of breast cancer (BC) cells when E and β-E2 are administered together and whether the underlying mechanism involves modulation of drug efflux transporters.Methods: MCF7 BC cells were treated with the vehicle only, E+β-E2, or E+β-E2+CM repeatedly for 8 weeks. Afterward, the cells were harvested, counted, and isolated for total RNA extraction. Total RNA was then processed into cDNA and further processed for the determination of mRNA expression patterns of drug efflux transporters (P-glycoprotein, BCRP, and MRP1). Results:Decreased sensitivity of BC cells was shown by the increased cell viability of MCF7 cells after 8 weeks. This condition was accompanied with increased mRNA expression of P-glycoprotein, BCRP, and MRP1 in cells treated with E+β-E2, as compared with the vehicle only. CM, administered in combination with E+β-E2, resulted in decreased cell viability versus E and β-E2 and also decreased in mRNA expression of P-glycoprotein, BCRP, and MRP1.Conclusion: CM partially reversed the sensitivity loss of BC cells to E in the presence of β-E2 by modulating drug efflux transporters.